R. K. ROBINS

1.9k total citations
73 papers, 1.5k citations indexed

About

R. K. ROBINS is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, R. K. ROBINS has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Organic Chemistry, 34 papers in Molecular Biology and 17 papers in Epidemiology. Recurrent topics in R. K. ROBINS's work include Synthesis and Characterization of Heterocyclic Compounds (23 papers), Biochemical and Molecular Research (20 papers) and Synthesis and Biological Evaluation (13 papers). R. K. ROBINS is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (23 papers), Biochemical and Molecular Research (20 papers) and Synthesis and Biological Evaluation (13 papers). R. K. ROBINS collaborates with scholars based in United States, Sweden and United Kingdom. R. K. ROBINS's co-authors include P G Canonico, John W. Huggins, Prem C. Srivastava, Patricia A. McKernan, V. L. Narayanan, Jacqueline Plowman, D B Wasson, Jane Montgomery, Jonathan Kaye and Buddy Ullman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

R. K. ROBINS

67 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. K. ROBINS United States 22 757 397 348 343 170 73 1.5k
Alexander Bloch United States 25 1.3k 1.7× 310 0.8× 201 0.6× 507 1.5× 93 0.5× 89 2.0k
Hubert Hřebabecký Czechia 18 656 0.9× 472 1.2× 223 0.6× 466 1.4× 154 0.9× 104 1.2k
G. A. LePage United States 29 1.7k 2.2× 352 0.9× 418 1.2× 324 0.9× 192 1.1× 106 2.4k
Janet L. Rideout United States 16 1.1k 1.5× 1.2k 3.0× 726 2.1× 358 1.0× 144 0.8× 33 2.5k
Sue C. Shaddix United States 18 686 0.9× 444 1.1× 184 0.5× 274 0.8× 178 1.0× 35 1.3k
R W Brockman United States 32 1.7k 2.3× 447 1.1× 350 1.0× 376 1.1× 348 2.0× 70 2.7k
James R. Appleman United States 26 1.0k 1.4× 219 0.6× 283 0.8× 203 0.6× 108 0.6× 66 1.7k
L. Lee Bennett United States 28 1.5k 2.0× 494 1.2× 419 1.2× 266 0.8× 329 1.9× 80 2.3k
Linda L. Wotring United States 22 632 0.8× 233 0.6× 223 0.6× 684 2.0× 46 0.3× 69 1.5k
George W. Koszalka United States 24 1.2k 1.6× 593 1.5× 855 2.5× 508 1.5× 122 0.7× 56 2.4k

Countries citing papers authored by R. K. ROBINS

Since Specialization
Citations

This map shows the geographic impact of R. K. ROBINS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. K. ROBINS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. K. ROBINS more than expected).

Fields of papers citing papers by R. K. ROBINS

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. K. ROBINS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. K. ROBINS. The network helps show where R. K. ROBINS may publish in the future.

Co-authorship network of co-authors of R. K. ROBINS

This figure shows the co-authorship network connecting the top 25 collaborators of R. K. ROBINS. A scholar is included among the top collaborators of R. K. ROBINS based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. K. ROBINS. R. K. ROBINS is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Middleton, David A., R. K. ROBINS, Xiao‐Long Feng, et al.. (1997). The conformation of an inhibitor bound to the gastric proton pump. FEBS Letters. 410(2-3). 269–274. 29 indexed citations
2.
Parandoosh, Zahra, Boanerges Rubalcava, Rick A. Finch, R. K. ROBINS, & Thomas L. Avery. (1990). Changes in diacylglycerol and membrane associated protein kinase C activity reflect the growth status of xenografted human mammary carcinoma treated with 8-Cl-cAMP. Cancer Letters. 49(3). 195–200. 5 indexed citations
3.
4.
Larson, S. B., et al.. (1990). Structure of sulfonosine. Acta Crystallographica Section C Crystal Structure Communications. 46(3). 512–515.
5.
Smee, Donald F., et al.. (1990). Antiviral activity of the novel immune modulator 7-thia-8-oxoguanosine.. PubMed. 9(1). 24–32. 18 indexed citations
6.
Larson, S. B., Ganesh D. Kini, & R. K. ROBINS. (1990). Structure of 5'-O-sulfamoylribavirin, an antiparasitic agent. Acta Crystallographica Section C Crystal Structure Communications. 46(6). 1135–1138. 1 indexed citations
7.
Saunders, Priscilla P., et al.. (1989). Phosphorylation of 3-deazaguanosine by nicotinamide riboside kinase in Chinese hamster ovary cells.. PubMed. 49(23). 6593–9. 11 indexed citations
8.
Larson, S. B., Howard B. Cottam, & R. K. ROBINS. (1989). Structure of 7-methyl-8-oxo-7,8-dihydroguanosine monohydrate. Acta Crystallographica Section C Crystal Structure Communications. 45(12). 1979–1983. 3 indexed citations
9.
Ghose, Arup K., Vellarkad N. Viswanadhan, Yogesh S. Sanghvi, et al.. (1989). Structural mimicry of adenosine by the antitumor agents 4-methoxy- and 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine as viewed by a molecular modeling method.. Proceedings of the National Academy of Sciences. 86(21). 8242–8246. 17 indexed citations
10.
Larson, S. B., Jack D. Anderson, Howard B. Cottam, & R. K. ROBINS. (1989). Structure of the sodium salt of a thiazolopyrimidine, a guanine analog. Acta Crystallographica Section C Crystal Structure Communications. 45(7). 1073–1076. 1 indexed citations
11.
SMEE, D. F., et al.. (1989). Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent. Antimicrobial Agents and Chemotherapy. 33(9). 1487–1492. 42 indexed citations
12.
Tagliaferri, P, Dionyssios Katsaros, Timothy Clair, et al.. (1988). Reverse transformation of Harvey murine sarcoma virus-transformed NIH/3T3 cells by site-selective cyclic AMP analogs.. Journal of Biological Chemistry. 263(1). 409–416. 47 indexed citations
13.
Revankar, Ganapathi R., et al.. (1987). Direct Synthesis of Pyrrole Nucleosides by the Stereospecific Sodium Salt Glycosylation Procedure. Nucleosides and Nucleotides. 6(1-2). 261–264. 3 indexed citations
14.
Sidwell, R. W., et al.. (1985). Activity of selenazofurin against influenza A and B viruses in vitro. Antimicrobial Agents and Chemotherapy. 28(3). 375–377. 20 indexed citations
15.
16.
ROBINS, R. K., Prem C. Srivastava, V. L. Narayanan, Jacqueline Plowman, & Kenneth D. Paull. (1982). 2-.beta.-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. Journal of Medicinal Chemistry. 25(2). 107–108. 124 indexed citations
17.
18.
Revankar, Ganapathi R., Thomas R. Matthews, & R. K. ROBINS. (1976). ChemInform Abstract: SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF CERTAIN IMIDAZO(1,2‐A)PYRIMIDINES. Chemischer Informationsdienst. 7(13). 2 indexed citations
19.
Pickering, Michael V., J. T. WITKOWSKI, & R. K. ROBINS. (1976). ChemInform Abstract: SYNTHESIS OF 1‐(4‐THIO‐β‐D‐RIBOFURANOSYL)‐1,2,4‐TRIAZOLE‐3‐CARBOXAMIDE. Chemischer Informationsdienst. 7(40). 1 indexed citations
20.
Lynch, Brian M., R. K. ROBINS, & C. C. Cheng. (1958). 605. Potential purine antagonists. Part X. Purines and pyrazolopyrimidines: comparisons of ionisation. Journal of the Chemical Society (Resumed). 2973–2973. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Bloch Breakdown of academic impact, for papers by Hubert Hřebabecký Breakdown of academic impact, for papers by G. A. LePage Breakdown of academic impact, for papers by Janet L. Rideout Breakdown of academic impact, for papers by Sue C. Shaddix Breakdown of academic impact, for papers by R W Brockman Breakdown of academic impact, for papers by James R. Appleman Breakdown of academic impact, for papers by L. Lee Bennett Breakdown of academic impact, for papers by Linda L. Wotring Breakdown of academic impact, for papers by George W. Koszalka
Rankless by CCL
2026